SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-14-055677
Filing Date
2014-09-12
Accepted
2014-09-12 16:35:58
Documents
11
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A v387973_10ka.htm 10-K/A 799927
2 EXHIBIT 23.1 v387973_ex23-1.htm EX-23.1 2212
3 EXHIBIT 31.1 v387973_ex31-1.htm EX-31.1 10915
4 EXHIBIT 31.2 v387973_ex31-2.htm EX-31.2 10822
5 EXHIBIT 32.1 v387973_ex32-1.htm EX-32.1 5875
6 EXHIBIT 32.2 v387973_ex32-2.htm EX-32.2 5925
7 GRAPHIC tpg10.jpg GRAPHIC 141216
8 GRAPHIC tpg11a.jpg GRAPHIC 74340
9 GRAPHIC tpg11b.jpg GRAPHIC 42101
10 GRAPHIC tpg12.jpg GRAPHIC 48455
11 GRAPHIC tpg15.jpg GRAPHIC 30341
  Complete submission text file 0001144204-14-055677.txt   1301050
Mailing Address 4870 SADLER ROAD SUITE 300 GLEN ALLEN VA 23060
Business Address 4870 SADLER ROAD SUITE 300 GLEN ALLEN VA 23060 650-888-2422
AmpliPhi Biosciences Corp (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-23930 | Film No.: 141101172
SIC: 2836 Biological Products, (No Diagnostic Substances)